|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: MSAFP vs triple screenFrom: ATB28@aol.comFri Jul 11 07:06:59 1997
In a message dated 97-07-10 14:36:54 EDT, sam@saidi.prestel.co.uk (Samir Saidi) writes: << If you screen all your patients (incl. <35) with double/triple testing >> You seem to have a basic flaw in your understanding of the *screening* process. In ocntrast to those patients who manifest a priori increased risk for fetal genetic disorders (e.g., maternal age > 34 years; previous child with chromosome abnormality; parental chromosome rearrangment; etc.), screening is the process of first choice in low risk patients (such as those < age 35 years). In the US, the standard of care is to offer multiple marker screening to all low-risk pregnant women (ACOG Technical Bulletin #141; August, 1994). Allan T. Bombard, MD Director, Division of Reproductive Genetics Dept of Obstetrics and Gynecology & Women's Health Albert Einstein College of Medicine Bronx, NY
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Sun Nov 2 05:08:30 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.